Drug Topics
AUGUST 29, 2024
As research continues to uncover the potential benefits of psilocybin, pharmacists and other clinicians have an essential role in bridging ancient wisdom with contemporary science.
PharmaVoice
AUGUST 29, 2024
Cognition Therapeutics touted what the C-suite saw as a promising mid-stage study in Alzheimer’s, but investors read a different story.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
AUGUST 29, 2024
Stephanie Sober, MD, MSHP, investigator on the pivotal research that supported the prescription-to-OTC switch of Opill, shares insights on how the medicine is reshaping the reproductive landscape.
Pharmacy Times
AUGUST 29, 2024
Pharmacists can provide extra resources for patients, including explanations of the therapy options for the patients, the course of therapy, and what patients can expect.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
AUGUST 29, 2024
Results from the INTEGUMENT-OLE phase 3 trial showed the therapy was also well-tolerated, with no new safety signals observed during treatment of up to 56 weeks.
STAT
AUGUST 29, 2024
On Thursday, the California Department of Food and Agriculture announced it is investigating the possible introduction of H5N1 bird flu in cattle at three dairy farms in the Central Valley. If confirmed, they would be the first known cases in that state. In a statement, officials said testing of samples from the three farms is currently underway in the state’s veterinary diagnostic lab.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
AUGUST 29, 2024
Hims & Hers, one of the largest publicly traded telehealth companies in the country, has supercharged its business in the last several months by offering compounded versions of the patented weight loss drugs known as GLP-1s. It’s staking its future on the drugs, with plans to continue selling compounded GLP-1s even when shortages of the versions approved by regulators come to an end — a strategy that policy experts say could land the company in court.
Pharmacy Times
AUGUST 29, 2024
Pharmacists support treatment adherence as well as monitor adverse effects, drug-drug interactions, and quality of life.
STAT
AUGUST 29, 2024
Concerns over health care’s carbon footprint typically revolve around issues like overly-air-conditioned hospitals and single-use medical supply waste. But researchers like Stanford University’s Jyothi Tirumalasetty think that asthma inhalers are also a good place to start when it comes to reducing emissions. Metered-dose inhalers, the most common type used to treat asthma or chronic obstructive pulmonary disease (COPD), use a propellant gas to aerosolize medications, which p
Pharmacy Times
AUGUST 29, 2024
The findings further the understanding of respiratory virus immune evasion mechanisms and uncover how RSV-NS1 can target therapeutic intervention
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
AUGUST 29, 2024
A key legislator is accusing the leaders of the three largest pharmacy benefit managers of making fraudulent statements during a hearing last month on the industry. | A key legislator is accusing the leaders of the three largest pharmacy benefit managers of making fraudulent statements during a hearing last month on the industry.
Pharmacy Times
AUGUST 29, 2024
Pharmacists can help facilitate more organized efforts to improve measles vaccination uptake for children aged 5 and younger by identifying socio-demographic gaps within this population.
STAT
AUGUST 29, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey there. We await one of the year’s biggest biotech readouts, and have lots of GLP-1 news today: Eli Lilly’s offer to slash pricing for Zepbound isn’t as magnanimous as it appears, and more.
Pharmacy Times
AUGUST 29, 2024
Expert shares reasons why many women are behind on their annual breast cancer screenings, along with the latest cutting edge treatments in the breast cancer space.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
AUGUST 29, 2024
I dreamed of having children from a young age — so much so that I assumed I had to be a cisgender woman. Society had taught me that only a cisgender woman would want so badly to carry and birth a child, so I suppressed any feelings that suggested I might not be a cisgender woman. I did not realize I was transgender until well after I had my children.
Fierce Healthcare
AUGUST 29, 2024
As artificial intelligence tools make their way into hospitals and doctor's offices, Elation Health saw a big opportunity to leverage its expertise in building clinical-first tech to roll out AI pu | As artificial intelligence tools make their way into hospitals and doctor's offices, Elation Health saw a big opportunity to leverage its expertise in building clinical-first tech to roll out AI purpose-built for primary care doctors.
pharmaphorum
AUGUST 29, 2024
Novartis partners with startup Lindy in a near-$1bn deal to develop subcutaneous formulations of biologic drugs
STAT
AUGUST 29, 2024
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. Labor Day is almost here, which means the sprint to the end of 2024 is upon us. If you’re reading this late-August newsletter from the beach, the pool, or the mountains, I thank you for it.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
AUGUST 29, 2024
Despite competing against several drugs that have been approved to fend off migraine headaches, AbbVie’s Ubrelvy (ubrogepant) —which is approved only to treat them—has carved out a significant nich | Recent trial results indicate that AbbVie's migraine treatment Ubrelvy works as a preventative. In a study published this week in the journal Neurology, Ubrelvy was 73% more effective in preventing a migraine attack than placebo.
pharmaphorum
AUGUST 29, 2024
Digital health firm Curio raises $10m+ in first-round financing that will be used to fund the rollout of its MamaLift Plus app for postpartum depression
Fierce Pharma
AUGUST 29, 2024
A Merck & Co. effort to move its PD-1 behemoth Keytruda into early treatment of lung cancer has reached a dead end, along with another bid to expand into a type of early-stage skin cancer. | A Merck & Co. effort to move its PD-1 behemoth Keytruda into early treatment of lung cancer has reached a dead end, along with another bid to expand into a type of early-stage skin cancer.
pharmaphorum
AUGUST 29, 2024
Shares in Neurocrine Biosciences took a tumble after it reported mid-stage data for a key pipeline drug for schizophrenia that failed to impress investors
STAT
AUGUST 29, 2024
What’s behind the “great abandonment” in gene therapy R&D? How does a startup spend $213 million? And is Adam an optimist? We talk about all that and more on this week’s episode of “The Readout LOUD.” STAT biotech reporter Jonathan Wosen joins us to discuss gene therapy pioneer Jim Wilson’s exit from his decades-long tenure at the University of Pennsylvania.
pharmaphorum
AUGUST 29, 2024
GSK gets EU approval for its RSV vaccine Arexvy in a younger age group, a potential leg-up in a market tussle with Pfizer and Moderna
The Checkup by Singlecare
AUGUST 29, 2024
Heartburn is incredibly common during pregnancy, especially in the second and third trimesters. If you find yourself dreading that churning, burning feeling before every meal, don’t fret. Pregnancy-safe treatments and remedies, such as famotidine (commonly known by its brand names Pepcid AC and Zantac 360 ), can help. Famotidine belongs to a class of medications called histamine-2 receptor antagonists ( H2 blockers for short).
Pharmaceutical Commerce
AUGUST 29, 2024
The latest news for pharma industry insiders.
STAT
AUGUST 29, 2024
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in your inbox. Good morning and happy Thursday! Yesterday it was announced that my colleague Usha Lee McFarling won the 2024 Victor Cohn Prize for Excellence in Medical Science Reporting. I’m genuinely so honored to work in the same newsroom as Usha. Her stories — read them all — have elucidated so many under-covered, unresolved racial health inequities within in our health care syst
Pharmaceutical Commerce
AUGUST 29, 2024
Panel offers suggestions on how compliance teams should be considering handling SOPs, stabilization, and much more.
pharmaphorum
AUGUST 29, 2024
Learn about drug repositioning, a strategy that involves finding new uses for existing drugs. Discover how this approach brings forgotten assets from shelves to patients and contributes to drug development.
Fierce Healthcare
AUGUST 29, 2024
The Department of Health and Human Services (HHS) is dropping its appeal of a June U.S. | The department's white flag came 10 days after the administration had filed its appeal of the June decision to the Fifth Circuit.
pharmaphorum
AUGUST 29, 2024
Bayer takes oral anti-HER2 drug into phase 3 for HER2-altered lung cancer, a key pillar of its drive to become a major player in oncology
The Checkup by Singlecare
AUGUST 29, 2024
Around 1 in 10 Americans have some type of eczema , which means 10% of the country deals with dry, itchy, inflamed, scaly skin or lesions. Dupixent (dupilumab) is a biologic monoclonal antibody medication that can help treat moderate-to-severe atopic dermatitis (AD), as well as asthma, chronic rhinosinusitis, and nasal polyps. Although it can relieve some of this skin disease’s most irritating symptoms, dupilumab treatment may also cause side effects, specifically a facial rash and facial erythe
pharmaphorum
AUGUST 29, 2024
Follow along on a journey from deep depression to mental health advocacy, discovering ways to cope and support others along the way.
Expert insights. Personalized for you.
447 
Let's personalize your content